Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.
By C. Kalka, H. Masuda, Tomono Takahashi, W. Kalka-Moll, Marcy Silver, M. Kearney, Tong Li, J. Isner, T. Asahara. Proceedings of the National Academy of Sciences of the United States of America, 2000
2,066 citations recorded by the source corpus.
Subfields: Cell Biology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/a6f0429a76b621b5a574f4026bc543fac84f3a51
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cell Biology
In Molecular Biology
- Stefanie Dimmeler
- A. Zeiher
- C. Urbich
- M. Laflamme
- C. Heeschen
- Alexandra Aicher
- Charles E. Murry
- Nikolaos G. Frangogiannis
Citations in the corpus
- HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. (2001, methodology): “Louis, Missouri, USA) as described previously (2, 4, 5, 24).”
- Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. (2000, background): “(67), who showed that transplantation of adult peripheral bloodderived EPCs significantly augmented ischemiainduced neovascularization in the hindlimb and promoted limb salvage in nude mice.”
- Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging. (2001, background): “Kalka et al (2000) studied the effects of new blood vessel formation over a 28-day period of treatment with angiogenic cytokines.”
- Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. (2005, methodology): “before the cell transplantation as described previously (14, 51).”
- Regenerating the heart (2005, methodology): “used a different, but widely accepted, method to derive EPC”